Skip to main content
. 2015 Mar 16;80(3):589–598. doi: 10.1111/bcp.12626

Figure 1.

Figure 1

Percentage of patients prescribed a gastroprotective strategy per year for each upper gastrointestinal event risk group (as defined separately for each cohort). LDA, low-dose aspirin; NSAID, UGIE, upper gastrointestinal event